AMAG Pharmaceuticals Income

What is the Income of AMAG Pharmaceuticals?

The Income of AMAG Pharmaceuticals, Inc. is -$227.96

What is the definition of Income?

Net income available for common shareholders equals net income minus preferred dividends paid.

ttm (trailing twelve months)

Net income available to common shareholders are the profits remaining after the company pays all of its suppliers, employees, service providers, creditors, and preferred shareholders. In other words, this is revenue less all expenses and preferred dividends. The number measures common shareholders' claim on the company's cash flows.

Income of companies in the Health Care sector on NASDAQ compared to AMAG Pharmaceuticals

What does AMAG Pharmaceuticals do?

AMAG Pharmaceuticals, Inc. is a biopharmaceutical company. It focuses on the manufacture, development, and commercialization of a therapeutic iron compound to treat iron deficiency anemia. The firm focuses on the development and commercialization of Feraheme injection for intravenous use to treat iron deficiency anemia. It manufactures, develops, and commercializes products derived from its proprietary technology for use in treating human diseases. Its products include Intrarosa, Vyleesi, Makena, CBR, Feraheme, and MuGard. The company was founded on November 9, 1981 and is headquartered in Waltham, MA.

Companies with income similar to AMAG Pharmaceuticals